世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4687
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、末梢T細胞リンパ腫（PTCL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・末梢T細胞リンパ腫（PTCL）治療の市場動向
・企業の競争状況、市場シェア
・末梢T細胞リンパ腫（PTCL）治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、モノクローナル抗体療法、その他）
・末梢T細胞リンパ腫（PTCL）治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他）
・末梢T細胞リンパ腫（PTCL）治療の北米市場規模2016-2027（アメリカ、カナダ）
・末梢T細胞リンパ腫（PTCL）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・末梢T細胞リンパ腫（PTCL）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・末梢T細胞リンパ腫（PTCL）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・末梢T細胞リンパ腫（PTCL）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Bristol-Myers Squibb、Leadiant Biosciences、Pacira Pharmaceuticals (Skyepharma)、Spectrum Pharmaceuticals、Merck、Genmab AS）
・結論

Market Analysis and Insights: Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market
The global Peripheral T-Cell Lymphoma (PTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral T-Cell Lymphoma (PTCL) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral T-Cell Lymphoma (PTCL) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral T-Cell Lymphoma (PTCL) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral T-Cell Lymphoma (PTCL) Treatment market.

Global Peripheral T-Cell Lymphoma (PTCL) Treatment Scope and Market Size
Peripheral T-Cell Lymphoma (PTCL) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral T-Cell Lymphoma (PTCL) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Monoclonal Antibodies Therapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bristol-Myers Squibb
Leadiant Biosciences
Pacira Pharmaceuticals (Skyepharma)
Spectrum Pharmaceuticals
Merck
Genmab AS

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Monoclonal Antibodies Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Perspective (2016-2027)
2.2 Peripheral T-Cell Lymphoma (PTCL) Treatment Growth Trends by Regions
2.2.1 Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral T-Cell Lymphoma (PTCL) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral T-Cell Lymphoma (PTCL) Treatment Industry Dynamic
2.3.1 Peripheral T-Cell Lymphoma (PTCL) Treatment Market Trends
2.3.2 Peripheral T-Cell Lymphoma (PTCL) Treatment Market Drivers
2.3.3 Peripheral T-Cell Lymphoma (PTCL) Treatment Market Challenges
2.3.4 Peripheral T-Cell Lymphoma (PTCL) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peripheral T-Cell Lymphoma (PTCL) Treatment Players by Revenue
3.1.1 Global Top Peripheral T-Cell Lymphoma (PTCL) Treatment Players by Revenue (2016-2021)
3.1.2 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue
3.4 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Concentration Ratio
3.4.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue in 2020
3.5 Peripheral T-Cell Lymphoma (PTCL) Treatment Key Players Head office and Area Served
3.6 Key Players Peripheral T-Cell Lymphoma (PTCL) Treatment Product Solution and Service
3.7 Date of Enter into Peripheral T-Cell Lymphoma (PTCL) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral T-Cell Lymphoma (PTCL) Treatment Breakdown Data by Type
4.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Type (2022-2027)

5 Peripheral T-Cell Lymphoma (PTCL) Treatment Breakdown Data by Application
5.1 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (2016-2027)
6.2 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type
6.2.1 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021)
6.2.2 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027)
6.2.3 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2027)
6.3 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application
6.3.1 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021)
6.3.2 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027)
6.3.3 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2027)
6.4 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country
6.4.1 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021)
6.4.2 North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (2016-2027)
7.2 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type
7.2.1 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2027)
7.3 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application
7.3.1 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2027)
7.4 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country
7.4.1 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type
8.2.1 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application
8.3.1 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Region
8.4.1 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (2016-2027)
9.2 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type
9.2.1 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2027)
9.3 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application
9.3.1 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2027)
9.4 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country
9.4.1 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type
10.2.1 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application
10.3.1 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country
10.4.1 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.1.4 Pfizer Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.2.4 Bristol-Myers Squibb Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Leadiant Biosciences
11.3.1 Leadiant Biosciences Company Details
11.3.2 Leadiant Biosciences Business Overview
11.3.3 Leadiant Biosciences Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.3.4 Leadiant Biosciences Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.3.5 Leadiant Biosciences Recent Development
11.4 Pacira Pharmaceuticals (Skyepharma)
11.4.1 Pacira Pharmaceuticals (Skyepharma) Company Details
11.4.2 Pacira Pharmaceuticals (Skyepharma) Business Overview
11.4.3 Pacira Pharmaceuticals (Skyepharma) Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.4.4 Pacira Pharmaceuticals (Skyepharma) Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.4.5 Pacira Pharmaceuticals (Skyepharma) Recent Development
11.5 Spectrum Pharmaceuticals
11.5.1 Spectrum Pharmaceuticals Company Details
11.5.2 Spectrum Pharmaceuticals Business Overview
11.5.3 Spectrum Pharmaceuticals Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.5.4 Spectrum Pharmaceuticals Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.5.5 Spectrum Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.6.4 Merck Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Genmab AS
11.7.1 Genmab AS Company Details
11.7.2 Genmab AS Business Overview
11.7.3 Genmab AS Peripheral T-Cell Lymphoma (PTCL) Treatment Introduction
11.7.4 Genmab AS Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
11.7.5 Genmab AS Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Monoclonal Antibodies Therapy
Table 5. Key Players of Others
Table 6. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Regions (2016-2021)
Table 10. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Regions (2022-2027)
Table 12. Peripheral T-Cell Lymphoma (PTCL) Treatment Market Trends
Table 13. Peripheral T-Cell Lymphoma (PTCL) Treatment Market Drivers
Table 14. Peripheral T-Cell Lymphoma (PTCL) Treatment Market Challenges
Table 15. Peripheral T-Cell Lymphoma (PTCL) Treatment Market Restraints
Table 16. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Peripheral T-Cell Lymphoma (PTCL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment as of 2020)
Table 19. Ranking of Global Top Peripheral T-Cell Lymphoma (PTCL) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peripheral T-Cell Lymphoma (PTCL) Treatment Product Solution and Service
Table 23. Date of Enter into Peripheral T-Cell Lymphoma (PTCL) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 66. Pfizer Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 71. Bristol-Myers Squibb Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Leadiant Biosciences Company Details
Table 74. Leadiant Biosciences Business Overview
Table 75. Leadiant Biosciences Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 76. Leadiant Biosciences Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 77. Leadiant Biosciences Recent Development
Table 78. Pacira Pharmaceuticals (Skyepharma) Company Details
Table 79. Pacira Pharmaceuticals (Skyepharma) Business Overview
Table 80. Pacira Pharmaceuticals (Skyepharma) Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 81. Pacira Pharmaceuticals (Skyepharma) Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 82. Pacira Pharmaceuticals (Skyepharma) Recent Development
Table 83. Spectrum Pharmaceuticals Company Details
Table 84. Spectrum Pharmaceuticals Business Overview
Table 85. Spectrum Pharmaceuticals Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 86. Spectrum Pharmaceuticals Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 87. Spectrum Pharmaceuticals Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 91. Merck Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Genmab AS Company Details
Table 94. Genmab AS Business Overview
Table 95. Genmab AS Peripheral T-Cell Lymphoma (PTCL) Treatment Product
Table 96. Genmab AS Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021) & (US$ Million)
Table 97. Genmab AS Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Monoclonal Antibodies Therapy Features
Figure 5. Others Features
Figure 6. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral T-Cell Lymphoma (PTCL) Treatment Report Years Considered
Figure 12. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Players in 2020
Figure 17. Global Top Peripheral T-Cell Lymphoma (PTCL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral T-Cell Lymphoma (PTCL) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue in 2020
Figure 19. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Peripheral T-Cell Lymphoma (PTCL) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type (2016-2027)
Figure 23. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application (2016-2027)
Figure 24. North America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Country (2016-2027)
Figure 25. United States Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Region (2016-2027)
Figure 41. China Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Peripheral T-Cell Lymphoma (PTCL) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 62. Leadiant Biosciences Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 63. Pacira Pharmaceuticals (Skyepharma) Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 64. Spectrum Pharmaceuticals Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 66. Genmab AS Revenue Growth Rate in Peripheral T-Cell Lymphoma (PTCL) Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3894 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B細胞非ホジキンリンパ腫（NHL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米...

世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4085 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚T細胞リンパ腫（CTCL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要...

世界の血管免疫芽球性T細胞リンパ腫（AILT）治療市場規模・現状・予測（2021年-2027年）

Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3806 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、血管免疫芽球性T細胞リンパ腫（AILT）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界の未分化大細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Large Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3800 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、未分化大細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のT細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global T-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4936 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、T細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、外科療法、幹細胞移植療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模...

世界の皮膚細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4076 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、皮膚細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模...

世界の成人T細胞白血病/リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3768 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、成人T細胞白血病/リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレンツキシマブベドチン、HBI-8000、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4588 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、非ホジキンリンパ腫＆慢性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（B細胞、T細胞）、用途別市場規模（化学療法、免疫療法、標的療法、放射線療法、幹細胞移植）、主要地域別市場規模（北米、...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
世界の皮膚細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Cell Lymphoma Treatment Market The global Cutaneous Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
世界の血管免疫芽球性T細胞リンパ腫（AILT）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market The global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…